| Keywords: |
neoplasms; t-lymphocytes; animal; mice; interleukin 2; cancer immunotherapy; drug structure; physiology; lymphatic system; immune tolerance; antibodies, monoclonal; recombinant proteins; killer cells, natural; short survey; molecular biology; macrophages; immunosuppressive treatment; bone marrow transplantation; graft vs host disease; drug determination; lymphocyte; therapy; interleukin-2; antigens, surface; receptors, immunologic; survey; antigens, differentiation, t-lymphocyte; interleukin 2 receptor; receptors, interleukin-2; immunization, passive; cyclosporins; human; priority journal; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; blood and hemopoietic system; drug analysis
|
